ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

In Brief: Salmon, Fidler Head ASCO, AACR; Durant, Pardee Presidents Elect; Namovicz, Other AOs Promoted

May 25, 1984

NCI audit Verifies Accuracy Of NSABP’s Lumpectomy Trial, B-06; Finds No Evidence Of Misrepresentation

October 21, 1994

Gene Therapy Shows Positive Results In Phase III Trial

July 25, 2008

Aventis, MediGene In Pact For Development Of Vaccine.

February 25, 2000

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976